Innovation pipelines

Our institute  has a wide range of technologies, capabilities and services available to industry.

Vaccines

Antigen discovery

Vaccine prototype

Preclinical studies

Phase 1 trials

Available/

Partnered

Group A Streptococcus (peptide conjugate)

x

x

x

x

A

Group A Streptococcus (liposomal formulation)

x

x

x

 

P

Malaria (attenuated whole parasite blood stage)

x

x

x

x

A

Neisseria gonorrhoeae (antigen)

x

x

  

A

Chikungunya virus (attenuated virus)

x

x

n

 

A

Zika virus (attenuated virus)

x

x

  

A

MultiVax (multiple antigen platform)

x

x

n

 

A

Drugs

Target Discovery

Hits /
Leads

Preclinical studies

Phase 1 trials

Available/

Partnered

Ross River Virus (small molecule)

x

x

x

x

P

Human Parainflunza Virus 1 & 3 (small molecule)

x

x

  

A

Influenza (small molecule)

x

x

  

A

Enterovirus 71 (small molecule)

x

x

  

A

Sepsis (small molecule)

x

x

x

x

P

Anticancer agent (peptide inhibitor)

x

x

  

A

Diagnostics, technology platforms and other

POC

Prototype

Lead Product

Available/

Partnered

Cancer diagnostic (biomarker)

x

  

A

Glycan Array (platform product)

x

x

x

P

Prebiotics and nutritional products

x

  

A

Get in touch

Contact the Business Development team